MoonLake Immunotherapeutics MLTX Switzerland — Number of operating leases
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept mnlk:NumberOfOperatingLeases.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's switzerland — number of operating leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's switzerland — number of operating leases?
- MoonLake Immunotherapeutics (MLTX) reported switzerland — number of operating leases of 2 in Q1 2026.
- How has MoonLake Immunotherapeutics's switzerland — number of operating leases changed year-over-year?
- MoonLake Immunotherapeutics's switzerland — number of operating leases increased by 300.0% year-over-year, from 0.5 to 2.
- What does switzerland — number of operating leases mean?
- This metric represents the total count of active operating lease agreements held by the company within the specified geographic segment. It provides insight into the company's physical footprint and operational infrastructure requirements in that region. Monitoring this figure helps investors assess the scale of fixed-asset commitments and potential future lease obligations.